-
Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans
Kalimuddin S, Tham CYL, Chan YFZ, Hang SK, Kunasegaran K, Chia A, Chan CYY, Ng DHL, Sim JXY, Tan HC, Syenina A, Ngoh AQ, Hamis NZ, Chew V, Leong YS, Yee JX, Low JG, Chan KR, Ong EZ, Bertoletti A, Ooi EE. Nat Microbiol. PubMed ID: 39794472
-
ASO1-adjuvanted vaccine alters baseline correlates of T cell response to varicella zoster virus in older adults
Chan CCY, Ooi JSG, Koh CWT, Ong EZ, Tham CYL, Yee JX, Chew VSY, Cheung YB, Ooi EE, Low JG, Chan KR. Vaccine. PubMed ID: 40592255
-
Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination
Zhong Y, Li J, Lee ARYB, Tan JYJ, Tay CJX, Koh CW, Seow EYT, Yap WC, Wong SY, Yau CE, Low CE, Tan KB, Young BE, Su Y, Devasia AG, Dharuman P, Lezhava A, Pandey R, Govindaraju PS, Yee S, Weng R, Khoo C, Tan SSY, Lee M, Lim J, Chan E, Ho CL,…
-
-
Dengue and severe dengue
Kalimuddin S, Chia PY, Low JG, Ooi EE. Clin Microbiol Rev. PubMed ID: 40910631
-
Glycans on non-structural protein 1 prevent premature T-cell mediated dengue virus clearance
Idris F, Ooi JSG, Ting DHR, Tan ETX, Wan C, Benke PI, Marzinek JK, Copping JM, Li QH, Ng LY, Lim SY, Walsh I, Allison JR, Bond PJ, Torta F, Nguyen-Khuong T, Chan KR, Alonso S. EMBO Mol Med. PubMed ID: 38689059
-
IgG, IgM and nonstructural protein 1 response profiles after receipt of tetravalent dengue vaccine TAK-003 in a phase 2 randomized controlled trial
Low JG, Oh HM, Leo YS, Kalimuddin S, Wijaya L, Pang J, Lee TH, Moss KJ, Brose M, Tricou V. Am J Trop Med Hyg. PubMed ID: 38806045
-
SINGHEALTH DUKE-NUS RESEARCH TEAM AWARD 2024
Correlates of Protection Against Symptomatic SARS-CoV-2 in Vaccinated Children
